Edinburgh Cancer Centre

Edinburgh UK EH4 2XU

3 studies enrolling now · 11 studies all time

What they study most

Acute Myeloid Leukemia, B-cell Malignancy, Brain Cancer, Breast Cancer, Cachexia, Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, GBM, Glioblastoma, Glioblastoma Multiforme, HPV Positive Oropharyngeal Squamous Cell Carcinoma

Studies at this site

• A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies — Recruiting now
• A Study of BGB-11417 in Participants With Myeloid Malignancies — Recruiting now
• A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1) — Recruiting now
• A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors — Running, not enrolling
• Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC — Completed
• Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy — Completed
• Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer — Completed
• Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin — Completed
• DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer — Completed
• NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer — Stopped early
• A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer — Completed